- Title
- Exploring para-thiophenols to expand the SAR of antimalarial 3-indolylethanones
- Creator
- Chisango, Ruramai Lissa
- ThesisAdvisor
- Veale, Clinton G L
- ThesisAdvisor
- Khanye, Setshaba
- Subject
- Antimalarials
- Subject
- Malaria Chemotherapy
- Subject
- Thiols
- Subject
- Plasmodium falciparum
- Subject
- Blood-brain barrier
- Date
- 2018
- Type
- Master's theses
- Type
- text
- Identifier
- http://hdl.handle.net/10962/63515
- Identifier
- vital:28428
- Description
- According to the WHO, malaria is responsible for over half a million deaths annually especially in populations from disadvantaged settings. Although there has been a documented improvement in the mortality rates, malaria has proved to be a global emergency. Mostly affecting the poor population, this disease is perpetuating a vicious cycle of poverty in the developing world as current preventive measures are not adequate unless adopted in addition to effective treatment. However, there has been a worldwide increase in resistance to available treatment which presents a need for novel, affordable treatment. A study conducted in our laboratory identified two hit thiophenol containing compounds 2.24 and 2.25. These molecules provided initial insight into the SAR and potential pharmacophore of this class of compounds. We decided to further explore these compounds by making bioisosteric replacements to optimize the structure as we monitor the effect of these modifications on the anti-plasmodial activity. The synthetic pathway to form the target compounds of our study comprised of three steps which were initiated by the Friedel-Crafts acetylation of the indoles resulting in compounds 3.5 - 3.7. A bromination step followed which yielded the -bromo ketones (3.8 - 3.11). Some of the thiophenols (3.14 and 3.16) were not readily available in our laboratory and so were synthesized for the final synthetic step. This step involved the nucleophilic displacement of the -bromine to generate the -aryl substituted 3-indolylethanones (3.17 - 3.27). The thioethers displayed improved antimalarial activity from 2.24 and 2.25 against the chloroquine sensitive 3D7 Plasmodium falciparum strain. In addition, these compounds were non-toxic against HeLa cells which indicated this potential novel class of antimalarials is selective for the malaria parasite as hypothesized in the previous study conducted in our laboratory. In an attempt to predict the bioavailability of some of our compounds, in silico studies were conducted revealing that these compounds could be passively absorbed by the gastrointestinal tract, a positive result for bioavailability purposes. However, results from these studies indicate that modifications of these compounds would be necessary to allow for permeation through the blood brain barrier (BBB) for instances when the patient has cerebral malaria.
- Description
- Thesis (MSc) -- Faculty of Pharmacy, Pharmacy, 2018
- Format
- computer, online resource, application/pdf, 1 online resource (94 pages), pdf
- Publisher
- Rhodes University, Faculty of Pharmacy, Pharmacy
- Language
- English
- Rights
- Chisango, Ruramai Lissa
- Rights
- Attribution 4.0 International (CC BY 4.0)
- Rights
- Open Access
- Hits: 4109
- Visitors: 4232
- Downloads: 169
Collections
RU Department of Pharmacy
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details | SOURCE1 | Adobe Acrobat PDF | 2 MB | Adobe Acrobat PDF | View Details |